Novavax Income Statement

Financials in millions USD. Fiscal year is January - December.

Millions USD. Fiscal year is Jan - Dec.

Fiscal Year	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021
Period Ending	Dec '25 Dec 31, 2025	Dec '24 Dec 31, 2024	Dec '23 Dec 31, 2023	Dec '22 Dec 31, 2022	Dec '21 Dec 31, 2021
Revenue	1,123	682.16	983.71	1,982	1,146
Revenue Growth (YoY)	64.69%	-30.65%	-50.37%	72.89%	141.02%
Cost of Revenue	73.04	202.74	343.77	902.64	-
Gross Profit	1,050	479.42	639.94	1,079	1,146
Selling, General & Admin	157.48	337.19	468.95	488.69	298.36
Research & Development	342.32	391.17	737.5	1,235	2,535
Other Operating Expenses	97.85	-	-	-	-
Operating Income	452.8	-248.93	-566.51	-644.74	-1,687
Interest Expense	-22.55	-20.08	-14.42	-19.88	-21.13
Other Non-Operating Income (Expense)	11.92	92.39	37.9	10.97	-6.83
Total Non-Operating Income (Expense)	-10.63	72.32	23.48	-8.91	-27.96
Pretax Income	442.17	-176.62	-543.03	-653.65	-1,715
Provision for Income Taxes	-1.87	-10.88	-2.03	-4.29	-29.22
Net Income	440.3	-187.5	-545.06	-657.94	-1,744
Net Income to Common	440.3	-187.5	-545.06	-657.94	-1,744
Shares Outstanding (Basic)	162	152	101	78	74
Shares Outstanding (Diluted)	173	152	101	78	74
Shares Change (YoY)	13.74%	51.03%	28.89%	5.08%	29.27%
EPS (Basic)	2.72	-1.23	-5.41	-8.42	-23.44
EPS (Diluted)	2.58	-1.23	-5.41	-8.42	-23.44
Free Cash Flow	-250.2	-100.32	-767.74	-504.99	268.45
Free Cash Flow Per Share	-1.45	-0.66	-7.62	-6.46	3.61
Gross Margin	93.50%	70.28%	65.05%	54.46%	100.00%
Operating Margin	40.30%	-36.49%	-57.59%	-32.53%	-147.13%
Profit Margin	39.19%	-27.49%	-55.41%	-33.20%	-152.12%
FCF Margin	-22.27%	-14.71%	-78.05%	-25.48%	23.42%
EBITDA	480.41	-200.44	-525.29	-615.68	-1,674
EBITDA Margin	42.76%	-29.38%	-53.40%	-31.07%	-146.03%
EBIT	452.8	-248.93	-566.51	-644.74	-1,687
EBIT Margin	40.30%	-36.49%	-57.59%	-32.53%	-147.13%
Effective Tax Rate	-0.42%	6.16%	0.37%	0.66%	1.70%

Updated Dec 31, 2025. Data Source: Fiscal.ai. Standard template. Financial Sources.